Back to results
RecruitingPhase 2

Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)

NCT07265596

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Institute for Neurodegenerative Disorders

New Haven, Connecticut, United States

+7 additional locations

Contact

Lianne Ramia

203-590-5600LRamia1@indd.org
View on ClinicalTrials.gov
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — TrialFind